The other substances we treat at The Grove Estate are benzodiazepines (e.g., Xanax, Valium), and alcohol. The substances that are treated at The Grove Estate in Indiana include:
From the 2021 NSDUH survey, an estimated 0.1% of Indiana residents aged 12 and older reported using heroin within the past year.
Alcohol
Addiciton to alcohol a depressant that is one of the most widely used drugs in the state. As reported by the CDC’s Behavioral Risk Factor Surveillance System (BRFSS), 50.0% of Indiana adults reported current alcohol use in 2020 compared to a national rate of 52.4%.
Opioids
Opioid addiction is a major problem in Indiana. Since 2017, opioid partial agonist prescriptions written by Indiana practitioners have risen by 138%, growing from 362,504 to 862,198. Similarly, prescriptions dispensed by Indiana pharmacies increased by 115.8%, from 408,654 to 891,151, as revealed by the Indiana State Government’s “Progress Report”.
Benzodiazepines
Benzodiazepine addiction accounts for a relatively small portion of substance use treatment admissions in Indiana when compared to opioids or methamphetamine. However, it remains a serious concern due to its frequent involvement in polysubstance abuse and its contribution to overdose risk. Nationally, benzodiazepine use is more prevalent than previously understood, with nearly 20% of all use considered misuse.
Stimulants
In State Fiscal Year (SFY) 2023, approximately 11% of all substance use treatment admissions in Indiana reported cocaine use as a primary, secondary, or tertiary substance, consistent with the previous year. Among these, 4% of treatment episodes identified cocaine as the primary substance of use, also unchanged from the prior year, according to the Indiana Division of Mental Health and Addiction.